
Pfizer made 4% less revenue in the first quarter of 2015 compared with the same period last year, the company’s …
Industry analysts predict 2015 will be another year of growth for the pharma, after approvals of new drugs soared to …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

